Departments of Surgery, Indiana University School of Medicine, Indianapolis, Indiana.
Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana.
Cancer Res. 2018 Sep 1;78(17):5107-5123. doi: 10.1158/0008-5472.CAN-18-0509. Epub 2018 Jul 11.
Cell-type origin is one of the factors that determine molecular features of tumors, but resources to validate this concept are scarce because of technical difficulties in propagating major cell types of adult organs. Previous attempts to generate such resources to study breast cancer have yielded predominantly basal-type cell lines. We have created a panel of immortalized cell lines from core breast biopsies of ancestry-mapped healthy women that form ductal structures similar to normal breast in 3D cultures and expressed markers of major cell types, including the luminal-differentiated cell-enriched ERα-FOXA1-GATA3 transcription factor network. We have also created cell lines from PROCR (CD201)/EpCAM cells that are likely the "normal" counterpart of the claudin-low subtype of breast cancers. RNA-seq and PAM50-intrinsic subtype clustering identified these cell lines as the "normal" counterparts of luminal A, basal, and normal-like subtypes and validated via immunostaining with basal-enriched KRT14 and luminal-enriched KRT19. We further characterized these cell lines by flow cytometry for distribution patterns of stem/basal, luminal-progenitor, mature/differentiated, multipotent PROCR cells, and organogenesis-enriched epithelial/mesenchymal hybrid cells using CD44/CD24, CD49f/EpCAM, CD271/EpCAM, CD201/EpCAM, and ALDEFLUOR assays and E-cadherin/vimentin double staining. These cell lines showed interindividual heterogeneity in stemness/differentiation capabilities and baseline activity of signaling molecules such as NF-κB, AKT2, pERK, and BRD4. These resources can be used to test the emerging concept that genetic variations in regulatory regions contribute to widespread differences in gene expression in "normal" conditions among the general population and can delineate the impact of cell-type origin on tumor progression. In addition to providing a valuable resource for the breast cancer research community to investigate cell-type origin of different subtypes of breast cancer, this study highlights interindividual differences in normal breast, emphasizing the need to use "normal" cells from multiple sources as controls to decipher the effects of cancer-specific genomic aberrations. .
细胞类型是决定肿瘤分子特征的因素之一,但由于在成年器官中繁殖主要细胞类型的技术困难,验证这一概念的资源稀缺。以前尝试生成此类资源来研究乳腺癌的研究主要产生了基底细胞系。我们从经过谱系映射的健康女性的核心乳腺活检中创建了一组永生化细胞系,这些细胞系在 3D 培养中形成类似于正常乳腺的导管结构,并表达主要细胞类型的标志物,包括腔细胞分化的 ERα-FOXA1-GATA3 转录因子网络。我们还从 PROCR(CD201)/EpCAM 细胞中创建了细胞系,这些细胞系可能是乳腺癌的 Claudin-low 亚型的“正常”对应物。RNA-seq 和 PAM50 内在亚型聚类将这些细胞系鉴定为 luminal A、基底和正常样亚型的“正常”对应物,并通过用基底富集的 KRT14 和腔细胞富集的 KRT19 进行免疫染色进行验证。我们还通过 CD44/CD24、CD49f/EpCAM、CD271/EpCAM、CD201/EpCAM 和 ALDEFLUOR 测定法以及 E-钙粘蛋白/波形蛋白双重染色,使用流式细胞术对这些细胞系进行了进一步表征,以确定干细胞/基底、腔前体、成熟/分化、多能性 PROCR 细胞和富含器官发生的上皮/间充质杂交细胞的分布模式。这些细胞系在干性/分化能力和 NF-κB、AKT2、pERK 和 BRD4 等信号分子的基线活性方面显示出个体间的异质性。这些资源可用于测试新兴概念,即调节区域的遗传变异导致一般人群中“正常”条件下基因表达的广泛差异,并阐明细胞类型起源对肿瘤进展的影响。除了为乳腺癌研究界提供一种有价值的资源,用于研究不同乳腺癌亚型的细胞类型起源外,本研究还强调了正常乳腺中的个体间差异,强调需要使用来自多个来源的“正常”细胞作为对照,以破译癌症特异性基因组异常的影响。